We are live on ! Find out more
RBFC

Roman Butler Fullerton & Co Portfolio holdings

AUM $419M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+31.15%
3 Year Est. Return
+120.62%
5 Year Est. Return
+172.72%
10 Year Est. Return
AUM
$201M
AUM Growth
+$7.72M
Cap. Flow
+$5.29M
Cap. Flow %
2.63%
Top 10 Hldgs %
28.37%
Holding
211
New
21
Increased
106
Reduced
54
Closed
22

Top Sells

Rank Stock Value
1
IWD icon
iShares Russell 1000 Value ETF
IWD
+$2.95M
2
HUM icon
Humana
HUM
+$1.3M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$1.28M
4
UNH icon
UnitedHealth
UNH
+$1.19M
5
BA icon
Boeing
BA
+$1.1M

Sector Composition

Rank Sector Weight
1 Technology 19.92%
2 Healthcare 12.1%
3 Financials 8.97%
4 Consumer Staples 8.04%
5 Consumer Discretionary 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PH icon
51
Parker-Hannifin
PH
$134B
$1.14M 0.57%
3,608
-145
-4% -$48K
PEP icon
52
PepsiCo
PEP
$189B
$1.12M 0.56%
5,909
+108
+2% +$18.9K
DE icon
53
Deere & Co
DE
$167B
$1.11M 0.55%
2,925
-967
-25% -$400K
BAC icon
54
Bank of America
BAC
$448B
$1.1M 0.55%
38,236
+4,342
+13% +$143K
SEDG icon
55
SolarEdge
SEDG
$2.05B
$1.09M 0.54%
3,528
+803
+29% +$245K
DG icon
56
Dollar General
DG
$26.5B
$1.09M 0.54%
4,962
-188
-4% -$42.2K
ULTA icon
57
Ulta Beauty
ULTA
$23.3B
$1.06M 0.53%
1,958
-501
-20% -$257K
PXD
58
DELISTED
Pioneer Natural Resource Co.
PXD
$1.05M 0.52%
+4,734
New +$1.02M
MCD icon
59
McDonald's
MCD
$194B
$1.04M 0.52%
3,572
+17
+0.5% +$4.55K
BMRN icon
60
BioMarin Pharmaceuticals
BMRN
$13.5B
$1.04M 0.52%
10,841
-3,796
-26% -$394K
ADBE icon
61
Adobe
ADBE
$105B
$996K 0.5%
2,696
+190
+8% +$67.5K
SSUS icon
62
Day Hagan/Ned Davis Research Smart Sector ETF
SSUS
$584M
$992K 0.49%
30,461
+6,375
+26% +$204K
TGT icon
63
Target
TGT
$69.2B
$986K 0.49%
6,255
-28
-0.4% -$4.6K
CAT icon
64
Caterpillar
CAT
$388B
$986K 0.49%
4,509
-4,474
-50% -$1.08M
IBM icon
65
IBM
IBM
$225B
$978K 0.49%
7,766
+2,125
+38% +$284K
ACLS icon
66
Axcelis
ACLS
$4.18B
$971K 0.48%
+8,160
New +$959K
IPAR icon
67
Interparfums
IPAR
$3.84B
$965K 0.48%
+6,271
New +$773K
IRM icon
68
Iron Mountain
IRM
$36.4B
$929K 0.46%
17,118
-404
-2% -$21.2K
ADP icon
69
Automatic Data Processing
ADP
$108B
$922K 0.46%
4,358
+300
+7% +$67.7K
PKW icon
70
Invesco BuyBack Achievers ETF
PKW
$1.77B
$917K 0.46%
10,918
+8
+0.1% +$700
VZ icon
71
Verizon
VZ
$196B
$908K 0.45%
24,344
+1,881
+8% +$74.2K
LNTH icon
72
Lantheus
LNTH
$6.57B
$903K 0.45%
+10,066
New +$649K
KO icon
73
Coca-Cola
KO
$372B
$870K 0.43%
13,621
+3,800
+39% +$230K
CVS icon
74
CVS Health
CVS
$120B
$856K 0.43%
11,753
-236
-2% -$19.8K
IWF icon
75
iShares Russell 1000 Growth ETF
IWF
$127B
$850K 0.42%
+14,204
New +$818K

Similar funds

Roman Butler Fullerton & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Roman Butler Fullerton & Co held 211 positions worth $201M, up 4% from $193M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Roman Butler Fullerton & Co's Q1 2023 filing shows 21 new, 106 increased, 54 reduced and 22 closed positions. Its largest new stake was Pioneer Natural Resource Co.: 4,734 shares worth $1.05M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.95M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Roman Butler Fullerton & Co's largest Q1 2023 buy was Pioneer Natural Resource Co.: 4,734 shares worth $1.05M.
  • Roman Butler Fullerton & Co added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $2.74M increase.
  • Roman Butler Fullerton & Co's biggest Q1 2023 reduction was UnitedHealth, cutting an estimated $1.19M.
  • Roman Butler Fullerton & Co fully exited iShares Russell 1000 Value ETF in Q1 2023, selling an estimated $2.95M.
  • Roman Butler Fullerton & Co's ten largest holdings make up 28% of its $201M portfolio in Q1 2023.
  • Roman Butler Fullerton & Co opened 21 new positions and closed 22 in Q1 2023.
  • Roman Butler Fullerton & Co's portfolio value rose 4% quarter-over-quarter to $201M.

Based on Roman Butler Fullerton & Co's 13F filing for Q1 2023, filed 27 Apr 2023.